Investor

22/06/20 -"Our FY20-21 EPS estimates see a substantial cut based on: 1) lower expected dividends paid from listed holdings, as some corporates have opted to cancel/reduce their dividend payments to conserve ..."

PDF page sample
Pages
63
Language
English
Published on
22/06/20
Download
You may also be interested by these reports :
21/11/25
Ackermans & van Haaren delivered a solid Q3 25, extending the strong trajectory established in the first half of the year. The group reiterated its ...
20/11/25
Amundi has set deliberately conservative 2028 targets to reflect uncertainty around the UniCredit agreement ending mid-2027. EPS guidance (€7) and a ...
20/11/25
We change our recommendation from Buy to Reduce as we now consider the likelihood of a takeover of Vivendi by Bolloré to be nil, erasing the ...
19/11/25
Vivendi is falling by 13% at the time of writing, following the release of an article in Le Monde suggesting that the French Supreme Court would ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO